Abstract
| Original language | English |
|---|---|
| Pages (from-to) | S3-S8 |
| Number of pages | 6 |
| Journal | European Journal of Cancer Prevention |
| Volume | 26 |
| Issue number | supp 1 |
| DOIs | |
| Publication status | Published - 2017 |
Fingerprint
Keywords
- Cancer data collection
- Cancer registries
- Data collection
- Europe
- Net survival
- Article
- Belgium
- breast cancer
- cancer diagnosis
- cancer localization
- cancer mortality
- cancer prognosis
- cancer registry
- cancer survival
- clinical protocol
- colon cancer
- death certificate
- esophagus cancer
- European
- follow up
- France
- head and neck cancer
- human
- Italy
- kidney cancer
- liver cancer
- lung cancer
- malignant neoplasm
- melanoma
- mortality rate
- ovary cancer
- pancreas cancer
- Portugal
- priority journal
- prostate cancer
- rectum cancer
- Spain
- stomach cancer
- Switzerland
- trend study
- uterine cervix cancer
- uterus cancer
Cite this
Trends in net survival from 15 cancers in six European Latin countries: The SUDCAN population-based study material. / Crocetti, E.; Bossard, N.; Uhry, Z.; Roche, L.; Rossi, S.; Capocaccia, R.; Faivre, J.; Serraino, Diego; Zucchetto, Antonella.
In: European Journal of Cancer Prevention, Vol. 26, No. supp 1, 2017, p. S3-S8.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Trends in net survival from 15 cancers in six European Latin countries: The SUDCAN population-based study material
AU - Crocetti, E.
AU - Bossard, N.
AU - Uhry, Z.
AU - Roche, L.
AU - Rossi, S.
AU - Capocaccia, R.
AU - Faivre, J.
AU - Serraino, Diego
AU - Zucchetto, Antonella
N1 - Cited By :15 Export Date: 20 February 2018 CODEN: EJUPE Correspondence Address: Crocetti, E.; Romagna Cancer Registry, Romagna Cancer Institute (IRST), IRCCS, via Piero Maroncelli, 40, Italy; email: emanuelecrocetti@yahoo.com
PY - 2017
Y1 - 2017
N2 - The aim of the SUDCAN collaborative study was to compare the net survival from 15 cancers diagnosed in 2000-2004 in six European Latin countries and provide trends in net survival and dynamics of excess mortality rates up to 5 years after diagnosis from 1992 to 2004 in France, Italy, Spain, and Switzerland, and from 2000 to 2004 in Belgium and Portugal. This paper presents a detailed description of the data analyzed and quality indicators. Incident cases from Belgium, France, Italy, Portugal, Spain, and Switzerland were retrieved from 56 general or specialized population-based cancer registries that participated in the EUROCARE-5 database. Fifteen cancer sites were analyzed. The data were checked according to the EUROCARE protocol. The percentages of excluded cases, cases based on death-certificate only, cases lost to follow-up at 5 years after diagnosis, and the proportions of microscopically verified cases were evaluated across countries and cancer sites. Data exclusions for major flaws were negligible. Cases based on death-certificate only were quite rare, except for some poor-prognosis cancers in some countries. The site-specific proportions of microscopically verified cases were generally high, but slightly lower in Italy than elsewhere. The percentage of cases lost to follow-up at 5 years after diagnosis was generally low. The net survival analyses in 2000-2004 included 873 314 tumors, whereas trend analyses included 1 426 004 tumors. The quality of the data analyzed was generally good. In fact, the analyzed data have been already checked and accepted for EUROCARE-5. However, slight differences in quality indexes, for some cancers, should be kept in mind in the interpretation of survival comparisons across countries. Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved.
AB - The aim of the SUDCAN collaborative study was to compare the net survival from 15 cancers diagnosed in 2000-2004 in six European Latin countries and provide trends in net survival and dynamics of excess mortality rates up to 5 years after diagnosis from 1992 to 2004 in France, Italy, Spain, and Switzerland, and from 2000 to 2004 in Belgium and Portugal. This paper presents a detailed description of the data analyzed and quality indicators. Incident cases from Belgium, France, Italy, Portugal, Spain, and Switzerland were retrieved from 56 general or specialized population-based cancer registries that participated in the EUROCARE-5 database. Fifteen cancer sites were analyzed. The data were checked according to the EUROCARE protocol. The percentages of excluded cases, cases based on death-certificate only, cases lost to follow-up at 5 years after diagnosis, and the proportions of microscopically verified cases were evaluated across countries and cancer sites. Data exclusions for major flaws were negligible. Cases based on death-certificate only were quite rare, except for some poor-prognosis cancers in some countries. The site-specific proportions of microscopically verified cases were generally high, but slightly lower in Italy than elsewhere. The percentage of cases lost to follow-up at 5 years after diagnosis was generally low. The net survival analyses in 2000-2004 included 873 314 tumors, whereas trend analyses included 1 426 004 tumors. The quality of the data analyzed was generally good. In fact, the analyzed data have been already checked and accepted for EUROCARE-5. However, slight differences in quality indexes, for some cancers, should be kept in mind in the interpretation of survival comparisons across countries. Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved.
KW - Cancer data collection
KW - Cancer registries
KW - Data collection
KW - Europe
KW - Net survival
KW - Article
KW - Belgium
KW - breast cancer
KW - cancer diagnosis
KW - cancer localization
KW - cancer mortality
KW - cancer prognosis
KW - cancer registry
KW - cancer survival
KW - clinical protocol
KW - colon cancer
KW - death certificate
KW - esophagus cancer
KW - European
KW - follow up
KW - France
KW - head and neck cancer
KW - human
KW - Italy
KW - kidney cancer
KW - liver cancer
KW - lung cancer
KW - malignant neoplasm
KW - melanoma
KW - mortality rate
KW - ovary cancer
KW - pancreas cancer
KW - Portugal
KW - priority journal
KW - prostate cancer
KW - rectum cancer
KW - Spain
KW - stomach cancer
KW - Switzerland
KW - trend study
KW - uterine cervix cancer
KW - uterus cancer
U2 - 10.1097/CEJ.0000000000000300
DO - 10.1097/CEJ.0000000000000300
M3 - Article
VL - 26
SP - S3-S8
JO - European Journal of Cancer Prevention
JF - European Journal of Cancer Prevention
SN - 0959-8278
IS - supp 1
ER -